It was also shown that in IDH-mutant glioblastomas and glioma cell lines there was uniformity in ZEB1 expression which led them to believe that this ubiquitous and robust expression pattern challenges the canonical concept of ZEB1 as a marker of EMT and tumor progression63. The gene discussed is ZEB1; the disease is central nervous system cancer.